Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (717)	12/18/1997 2:10:00 PM
From: Sigmund	Read Replies (2) \| Respond to of 1894

I am glad you contacted Stacie. Her answer is what I would have expected her to say but I think it best that you get it from her. From a layman's point of view, the ThinPrep should really lend itself to automated reading since it is a higher quality preparation. The only disadvantage I see for an automated equipment manufacturer is that it might be too easy and thus invite lots of competition. I think her answer re the 75% rejected slides also makes a lot of sense. Accumed, the way I see it, is more of a conventional information technology company and this part of the job .... i.e. supporting the cytotechs should be right up their alley. This also is good news for the cytotechs themselves. The philosophy that I have heard expressed is not to eliminate the techs but to expand the number of Pap tests conducted. If this can be done in a way that is less hard on the techs and allows them to use their professional qualifications more fully then it is a win/win situation. Job performance aids are being used almost everywhere so why not in the medical laboratory? It will be an exciting future for all concerned and most important of all good for the consumer.